Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (72)

2024

  1. Non-Mammalian Models for Understanding Neurological Defects in RASopathies

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis

    Biomedicines, Vol. 11, Núm. 7

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  4. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype

    Frontiers in Psychiatry, Vol. 12

  2. Effects of Therapeutic Antibodies on Gene and Protein Signatures in Asthma Patients: A Comparative Systematic Review

    Biomedicines, Vol. 10, Núm. 2

  3. Identification of Germinal Neurofibromin Hotspots

    Biomedicines, Vol. 10, Núm. 8

  4. Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease

    Genes, Vol. 13, Núm. 4

  5. Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Economic impact of the application of a precision medicine model (5SPM) on psychotic patients

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025

  2. Genetics and Epigenetics of Nasal Polyposis: A Systematic Review

    Journal of investigational allergology & clinical immunology, Vol. 31, Núm. 3, pp. 196-211

  3. IL-5 Receptor Subunit Alpha Expression As A Possible Biomarker In Asthma

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 2, pp. AB245

  4. Increased TPSAB1 Copy Number in a Family With Elevated Basal Serum Levels of Tryptase

    Frontiers in Medicine, Vol. 8

  5. Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  6. PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 9

  7. Review: Influence of the cyp450 genetic variation on the treatment of psychotic disorders

    Journal of Clinical Medicine, Vol. 10, Núm. 18

2020

  1. Application of a pharmacogenetics-based precision medicine model (5SPM) to psychotic patients that presented poor response to neuroleptic therapy

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-16

  2. Atopy can be an interfering factor in genetic association studies of ß-lactam allergy

    Journal of Investigational Allergology and Clinical Immunology

  3. Genetics and epigenetics of atopic dermatitis: An updated systematic review

    Genes, Vol. 11, Núm. 4